Literature DB >> 21548400

Of cancer and cave fish.

Robert A Gatenby1, Robert J Gillies, Joel S Brown.   

Abstract

We propose that the drivers of carcinogenesis lie more in the adaptive changes that are enabled by local or systemic alterations of tissue architecture than in the genetic changes observed in cancer cells. A full understanding of cancer biology and therapy through a cataloguing of the cancer genome is unlikely unless it is integrated into an evolutionary and ecological context.

Entities:  

Mesh:

Year:  2011        PMID: 21548400      PMCID: PMC3971416          DOI: 10.1038/nrc3036

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  9 in total

1.  Mapping a cave fish genome: polygenic systems and regressive evolution.

Authors:  R Borowsky; H Wilkens
Journal:  J Hered       Date:  2002 Jan-Feb       Impact factor: 2.645

2.  Restoring sight in blind cavefish.

Authors:  Richard Borowsky
Journal:  Curr Biol       Date:  2008-01-08       Impact factor: 10.834

Review 3.  Energy limitation as a selective pressure on the evolution of sensory systems.

Authors:  Jeremy E Niven; Simon B Laughlin
Journal:  J Exp Biol       Date:  2008-06       Impact factor: 3.312

4.  Distinct evolutionary patterns between two duplicated color vision genes within cyprinid fishes.

Authors:  Zhiqiang Li; Xiaoni Gan; Shunping He
Journal:  J Mol Evol       Date:  2009-10-17       Impact factor: 2.395

5.  Evolutionary dynamics of cancer prevention.

Authors:  Robert A Gatenby; Robert J Gillies; Joel S Brown
Journal:  Nat Rev Cancer       Date:  2010-08       Impact factor: 60.716

6.  Cloning of the alphaA-crystallin genes of a blind cave form and the epigean form of Astyanax fasciatus: a comparative analysis of structure, expression and evolutionary conservation.

Authors:  M Behrens; H Wilkens; H Schmale
Journal:  Gene       Date:  1998-08-31       Impact factor: 3.688

Review 7.  Regressive evolution in Astyanax cavefish.

Authors:  William R Jeffery
Journal:  Annu Rev Genet       Date:  2009       Impact factor: 16.830

Review 8.  Saturation density of skin fibroblasts as a quantitative screen for human cancer susceptibility.

Authors:  Harry Rubin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-09-01       Impact factor: 4.254

Review 9.  A microenvironmental model of carcinogenesis.

Authors:  Robert A Gatenby; Robert J Gillies
Journal:  Nat Rev Cancer       Date:  2008-01       Impact factor: 60.716

  9 in total
  42 in total

Review 1.  Microbiome, bile acids, and obesity: How microbially modified metabolites shape anti-tumor immunity.

Authors:  Laura M Sipe; Mehdi Chaib; Ajeeth K Pingili; Joseph F Pierre; Liza Makowski
Journal:  Immunol Rev       Date:  2020-05       Impact factor: 12.988

2.  Phenotypic changes of acid-adapted cancer cells push them toward aggressiveness in their evolution in the tumor microenvironment.

Authors:  Mehdi Damaghi; Robert Gillies
Journal:  Cell Cycle       Date:  2016-09-16       Impact factor: 4.534

Review 3.  Natural Selection in Cancer Biology: From Molecular Snowflakes to Trait Hallmarks.

Authors:  Angelo Fortunato; Amy Boddy; Diego Mallo; Athena Aktipis; Carlo C Maley; John W Pepper
Journal:  Cold Spring Harb Perspect Med       Date:  2017-02-01       Impact factor: 6.915

Review 4.  Metabolism and its sequelae in cancer evolution and therapy.

Authors:  Robert J Gillies; Robert A Gatenby
Journal:  Cancer J       Date:  2015 Mar-Apr       Impact factor: 3.360

5.  Thoughts for a new year.

Authors: 
Journal:  Nat Rev Cancer       Date:  2013-01       Impact factor: 60.716

Review 6.  Cancer Evolution-Development: experience of hepatitis B virus-induced hepatocarcinogenesis.

Authors:  W B Liu; J F Wu; Y Du; G W Cao
Journal:  Curr Oncol       Date:  2016-02-18       Impact factor: 3.677

Review 7.  Integrating evolutionary dynamics into cancer therapy.

Authors:  Robert A Gatenby; Joel S Brown
Journal:  Nat Rev Clin Oncol       Date:  2020-07-22       Impact factor: 66.675

Review 8.  A river model to map convergent cancer evolution and guide therapy in RCC.

Authors:  Elizabeth Y Wei; James J Hsieh
Journal:  Nat Rev Urol       Date:  2015-11-03       Impact factor: 14.432

9.  Tumor genetic analyses of patients with metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapy.

Authors:  Martin H Voss; A Ari Hakimi; Can G Pham; A Rose Brannon; Ying-Bei Chen; Luis F Cunha; Oguz Akin; Han Liu; Shugaku Takeda; Sasinya N Scott; Nicholas D Socci; Agnes Viale; Nikolaus Schultz; Chris Sander; Victor E Reuter; Paul Russo; Emily H Cheng; Robert J Motzer; Michael F Berger; James J Hsieh
Journal:  Clin Cancer Res       Date:  2014-03-12       Impact factor: 12.531

10.  Darwinian Dynamics of Intratumoral Heterogeneity: Not Solely Random Mutations but Also Variable Environmental Selection Forces.

Authors:  Mark C Lloyd; Jessica J Cunningham; Marilyn M Bui; Robert J Gillies; Joel S Brown; Robert A Gatenby
Journal:  Cancer Res       Date:  2016-03-23       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.